Scott E. Eggener to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Scott E. Eggener has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.055
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
Score: 0.055